Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
The Sonu Band, now FDA-cleared for children 12+, showed a -2.74 mean TNSS improvement with no adverse events in a 2-week study.
Allergy & Immunology July 3rd 2025
Journal of the American College of Cardiology (JACC)
The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.
Cardiology August 5th 2024
The Medical Futurist
Non-invasive digital health tools, including wearable sensors and tremor-suppressing devices, are emerging as valuable adjuncts to traditional treatments for tremor management, significantly enhancing patient autonomy and quality of life.
Internal Medicine May 28th 2024